Processa Pharmaceuticals (PCSA) Shares Outstanding (Entity) (2012 - 2026)
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - | 2.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.79 Mn |
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 622,772.00 |
| Mar 31, 2025 | 381,072.00 |
| Dec 31, 2024 | 122,396.00 |
| Sep 30, 2024 | 130,678.00 |
| Jun 30, 2024 | 114,755.00 |
| Mar 31, 2024 | 114,239.00 |
| Dec 31, 2023 | 51,440.00 |
| Sep 30, 2023 | 49,263.00 |
| Jun 30, 2023 | 49,063.00 |
| Mar 31, 2023 | 49,063.00 |
| Dec 31, 2022 | 32,071.00 |
| Sep 30, 2022 | 31,790.00 |
| Jun 30, 2022 | 31,639.00 |
| Mar 31, 2022 | 31,675.00 |
| Dec 31, 2021 | 31,420.00 |
| Sep 30, 2021 | 31,198.00 |